EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effects of Korean Red Ginseng combination therapy on HIV-infected patients treated with integrase strand transfer inhibitors

Young-Keol Cho, Jinny Lee, Jung-Eun Kim, Heungsup Sung

Journal of Ginseng Research · 2024-11 · 48 (6) · 603-608

DOI: 10.1016/j.jgr.2024.09.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ginseng Research, 2024-11. Verfasst von Young-Keol Cho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Ulsan College of Medicine, Seoul, Republic of Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Korean Red Ginseng (KRG) combined with antiretroviral therapy (ART) has shown benefits in the treatment of HIV-1-infected patients. Current guidelines recommend regimens containing integrase strand transfer inhibitors (INSTIs) as first-line treatment for these patients. The present study assessed the duration of effectiveness of ginseng combination therapy (GCT) in patients receiving INSTIs.

Methods

This study included 58 HIV-1-infected patients previously untreated with monotherapy or two-drug combination therapy. Patients in the GCT (n = 26) group received ART plus KRG for 164 ± 64 months, whereas patients in the control (n = 32) group received ART alone for 128 ± 49 months. Subsequently, patients in these two groups received INSTI for 81 ± 36 months and 68 ± 26 months, respectively.

Results

Before INSTI treatment, only one drug resistance mutation (DRM) was observed in the GCT group, compared with an overall resistance rate of 44.4 % in the control group (P < 0.001). The overall resistance rate was higher in the control than in the GCT group (9.5 % vs. 0.12 %, P < 0.001). During INSTI treatment, the resistance rate in the GCT group remained 0 % for over 5 years, but gradually decreased in the control group from 18.3 % to 13.9 % over 6 years, indicating that the between-group difference in resistance rate gradually decreased during INSTI treatment.

Conclusion

The beneficial effects of KRG were well maintained for more than 20 years, including the INSTI treatment period.

Schlagwörter

Stichwörter der Autor:innen

Antiretroviral therapyDrug resistance mutationsGCTINSTIKorean Red Ginseng

Autor:innen und Institutionen

  • Department of Microbiology, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Zitieren

APA

Cho, Y. K., Lee, J., Kim, J. E., & Sung, H. (2024). Effects of Korean Red Ginseng combination therapy on HIV-infected patients treated with integrase strand transfer inhibitors. Journal of Ginseng Research, 48(6), 603-608. https://doi.org/10.1016/j.jgr.2024.09.003

Vancouver

Cho YK, Lee J, Kim JE, Sung H. Effects of Korean Red Ginseng combination therapy on HIV-infected patients treated with integrase strand transfer inhibitors. Journal of Ginseng Research. 2024;48(6):603-608. doi:10.1016/j.jgr.2024.09.003

BibTeX
@article{Cho2024,
  author = {Cho, Young-Keol and Lee, Jinny and Kim, Jung-Eun and Sung, Heungsup},
  title = {Effects of Korean Red Ginseng combination therapy on HIV-infected patients treated with integrase strand transfer inhibitors},
  journal = {Journal of Ginseng Research},
  year = {2024},
  volume = {48},
  number = {6},
  pages = {603--608},
  doi = {10.1016/j.jgr.2024.09.003}
}
Kostenlos starten →